Orange Book product · Generic (ANDA)
FROVATRIPTAN SUCCINATE
FROVATRIPTAN SUCCINATE
At a glance
Apr 06, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 06, 2022
4 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
FROVATRIPTAN SUCCINATE
Strength
EQ 2.5MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 213891
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of FROVATRIPTAN SUCCINATE
- 2001FROVABrand (NDA)
NDA 021006 · ENDO OPERATIONS
- 2025FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 216998 · LEADING
- 2018FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 211292 · AMNEAL PHARMS CO
- 2016FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 204730 · GLENMARK PHARMS LTD
- 2014FROVATRIPTAN SUCCINATEGeneric (ANDA)
ANDA 202931 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
